Abstract
Since its earliest days, the history of human genetics has been checkered with actual, perceived, and potential abuses in the application of its scientific concepts to research or clinical endeavors. Aside from obvious cases of scientific fraud and continuing controversies over natural selection and biological determinism, a long and varied history of eugenics movements grew out of the (re)discovery of Mendel’s experiments at the beginning of the twentieth century. The term eugenics was first coined by Francis Galton in 1883 and defined as the science of improving the gene pool of the human species through selective breeding. The concept was soon extended well beyond its obvious and accepted precedent of animal husbandry to encompass social as well as physical traits, as Mendelian inheritance came to be viewed as the fundamental determinant of low intelligence, mental illness, substance abuse, physical handicaps, poverty, promiscuity, prostitution, and criminality. Eugenics thus provided a logical extension to the notion that such undesirable traits could be weeded out of the population through biological means rather than traditional social welfare policy, by enactment of restricted marriage laws, mandatory sterilization, euthanasia, or outright genocide. Of course, everyone knows that such policies reached their zenith (or nadir) in Nazi Germany, where the scope of supposedly genetic social traits to be eliminated through these means expanded to include race and ethnicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kevles, D. J. and Hood, L. (ed.) (1992) The Code of Codes: Scientific and Social Issues in the Human Genome Project, Harvard University Press, Cambridge, MA.
Nuremberg Code. (1949) Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10, vol. 2, U.S. Government Printing Office, Washington, DC.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979) The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research, U.S. Department of Health, Education and Welfare, Washington, DC.
United States Department of Energy. (1997) Human Genome Program Report, Part 1: Overview and Progress, U.S. Department of Energy, Germantown, MD.
Grody, W. W., Kronquist, K. E., Lee, E. U., Edmond, J., and Rome, L. H. (1993) PCR-based cystic fibrosis carrier screening in a first-year medical student biochemistry laboratory. Am. J. Hum. Genet. 53, 1352–1355.
Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., Booker, S. V., Parker, R. D., and Hamilton, S. R. (1997) The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N. Engl. J. Med. 336, 823–827.
Grody, W. W. (1999) Cystic fibrosis: Molecular diagnosis, population screening, and public policy. Arch. Pathol. Lab. Med. 123, 1041–1046.
Geller, G., Botkin, J. R., Green, M. J., Press, N., Biesecker, B. B., Wilfond, B., Grana, G., Daly, M. B., Schneider, K., and Kahn, M. J. E. (1997) Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. JAMA 277, 1467–1474.
Holtzman, N. A., Murphy, P. D., Watson, M. S., and Barr, P. A. (1997) Predictive genetic testing: From basic research to clinical practice. Science 278, 602–605.
Task Force on Genetic Testing. (1998) Promoting Safe and Effective Genetic Testing in the United States, Johns Hopkins University Press, Baltimore, MD.
American Society of Clinical Oncology. (1996) Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J. Clin. Oncol. 14, 81,730–81,736.
National Committee for Clinical Laboratory Standards. (1999) Molecular Diagnostic Methods for Genetic Diseases: Approved Guidelines, National Committee for Clinical Laboratory Standards, Wayne, PA.
Shattuck-Eidens, D., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., et al. (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing. JAMA 278, 1242–1250.
Billings, P., Cohn, M., de Cuevas, M., Beckwith, J., Alper, J., and Natowicz, M. (1992) Discrimination as a consequence of genetic testing. Am. J. Hum. Genet. 50, 476–82.
Hudson, K. L., Rothenberg, K. H., Andrews, L. B., Kahn, M. J. E., and Collins, F. S. (1995) Genetic discrimination and health insurance: An urgent need for reform. Science 270, 391–393.
Reilly, P. R. (1998) Rethinking risks to human subjects in genetic research. Am. J. Hum. Genet. 63, 682–685.
Botkin, J. R., McMahon, W. M., Smith, K. R., and Nash, J. E. (1998) Privacy and confidentiality in the publication of pedigrees: A survey of investigators and biomedical journals. JAMA 279, 1808–1812.
Byers, P. H. and Ashkenas, J. (1998) Pedigrees—Publish? or perish the thought? Am. J. Hum. Genet. 63, 678–681.
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11, 198–200.
Foster, M. W., Bersten, D., and Carter, T. H. (1998) A model agreement for genetic research in socially identifiable populations. Am. J. Hum. Genet. 63, 696–702.
Juengst, E. T. (1998) Group identity and human diversity: Keeping biology straight from culture. Am. J. Hum. Genet. 63, 673–677.
Pembrey, M. E. (1998) In the light of preimplantation genetic diagnosis: Some ethical issues in medical genetics revisited. Eur. J. Hum. Genet. 6, 4–11.
Clayton, E. W., Steinberg, K. K., Khoury, M. J., Thomson, E., Andrews, L., Kahn, M. J. E., Kopelman, L. M., and Weiss, J. O. (1995) Informed consent for genetic research on stored tissue samples. JAMA 274, 1786–1792.
Knoppers, B. M. and Laberge, C. M. (1995) Research and stored tissues: Persons as sources, samples as persons? JAMA 274, 1806–1807.
Grody, W. W. (1995) Molecular pathology, informed consent, and the paraffin block. Diagn. Molec. Pathol. 4, 155–157.
Grizzle, W., Grody, W. W., Noll, W. W., Sobel, M. E., Stass, S. A., Trainer, T., Travers, H., Weedn, V., and Woodruff, K. (1999) Recommended policies for uses of human tissue in research, education, and quality control. Arch. Pathol. Lab. Med. 123, 296–300.
American Society of Human Genetics. (1996) ASHG Report: Statement on informed consent for genetic research. Am. J. Hum. Genet. 59, 471–474.
Merz, J. F., Sankar, P., Taube, S. E., and LiVolsi, V. (1997) Use of human tissues in research: Clarifying clinician and researcher roles and information flows. J. Invest. Med. 45, 252–257.
Grody, W. W. and Watson, M. S. (1997) Those elusive molecular diagnostics CPT codes. Diagn. Mol. Pathol. 6, 131–133.
Garrett, C. T. and Ferreira-Gonzalez, A. (1996) FDA regulation of analyte-specific reagents (ASRs): Implications for nucleic acid-based molecular testing. Diagn. Mol. Pathol. 5, 151–153.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Grody, W.W. (2001). Ethical Ramifications of Genetic Analysis Using DNA Arrays. In: Rampal, J.B. (eds) DNA Arrays. Methods in Molecular Biology™, vol 170. Humana Press. https://doi.org/10.1385/1-59259-234-1:53
Download citation
DOI: https://doi.org/10.1385/1-59259-234-1:53
Publisher Name: Humana Press
Print ISBN: 978-0-89603-822-6
Online ISBN: 978-1-59259-234-0
eBook Packages: Springer Protocols